Osanetant is primarily researched for its potential therapeutic applications in the field of mental health, particularly in addressing mood disorders and anxiety. It functions as a neurokinin 3 receptor antagonist, which plays a role in modulating neurotransmitter activity in the brain. This mechanism makes it a candidate for treating conditions like depression and schizophrenia, where neurokinin signaling is often dysregulated. Additionally, it has been explored for its potential in managing menopausal symptoms, such as hot flashes, due to its influence on hormonal pathways. While still under investigation, Osanetant represents a promising avenue for developing novel treatments in psychiatry and endocrinology.